Cargando…
Editorial Comment: Abiraterone in “High-” and “Low-risk” Metastatic Hormone-sensitive Prostate Cancer
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Sociedade Brasileira de Urologia
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712714/ https://www.ncbi.nlm.nih.gov/pubmed/33047929 http://dx.doi.org/10.1590/S1677-5538.IBJU.2021.01.08 |
| _version_ | 1783618432009240576 |
|---|---|
| author | Lott, Felipe |
| author_facet | Lott, Felipe |
| author_sort | Lott, Felipe |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7712714 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Sociedade Brasileira de Urologia |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-77127142020-12-05 Editorial Comment: Abiraterone in “High-” and “Low-risk” Metastatic Hormone-sensitive Prostate Cancer Lott, Felipe Int Braz J Urol Update in Urology Sociedade Brasileira de Urologia 2020-11-18 /pmc/articles/PMC7712714/ /pubmed/33047929 http://dx.doi.org/10.1590/S1677-5538.IBJU.2021.01.08 Text en https://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Update in Urology Lott, Felipe Editorial Comment: Abiraterone in “High-” and “Low-risk” Metastatic Hormone-sensitive Prostate Cancer |
| title | Editorial Comment: Abiraterone in “High-” and “Low-risk” Metastatic Hormone-sensitive Prostate Cancer |
| title_full | Editorial Comment: Abiraterone in “High-” and “Low-risk” Metastatic Hormone-sensitive Prostate Cancer |
| title_fullStr | Editorial Comment: Abiraterone in “High-” and “Low-risk” Metastatic Hormone-sensitive Prostate Cancer |
| title_full_unstemmed | Editorial Comment: Abiraterone in “High-” and “Low-risk” Metastatic Hormone-sensitive Prostate Cancer |
| title_short | Editorial Comment: Abiraterone in “High-” and “Low-risk” Metastatic Hormone-sensitive Prostate Cancer |
| title_sort | editorial comment: abiraterone in “high-” and “low-risk” metastatic hormone-sensitive prostate cancer |
| topic | Update in Urology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712714/ https://www.ncbi.nlm.nih.gov/pubmed/33047929 http://dx.doi.org/10.1590/S1677-5538.IBJU.2021.01.08 |
| work_keys_str_mv | AT lottfelipe editorialcommentabirateroneinhighandlowriskmetastatichormonesensitiveprostatecancer |